Immortalized Human Strital Precursors as a Cell Model of HD
Immortalized Human Strital Precursors as a Cell Model of HD
批准号:
8533521
负责人:
Christopher A Ross
金额:
$24.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-02-15 至 2015-01-31
关键词:
AgonistBiochemicalBiological AssayBrain-Derived Neurotrophic FactorCAG repeatCell Differentiation processCell LineCell LineageCell modelCellsCellular biologyCorpus striatum structureDevelopmentDiseaseDisease modelFundingGoalsHeterogeneityHumanHuman DevelopmentHuntington DiseaseIndividualKnock-in MouseLengthModelingMusNational Institute of Neurological Disorders and StrokeNeuronsNoisePathogenesisPhenotypeProtocols documentationPublishingRestSeriesSeveritiesSignal TransductionStem cellsTestingTherapeuticToxic effectTransfectionViral Vectorhuman Huntingtin proteininduced pluripotent stem cellmouse modelmutantnoveloverexpressionpublic health relevancerelating to nervous systemscreeningsmall molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cell models of Huntington's disease have been very important for understanding the cell biology of the disorder and for testing potential therapeutics The recent development of human induced pluripotent stem cell (iPSC) models has greatly enhanced our ability to model disease in human cells. As part of the NINDS funded HD iPSC Consortium, we have developed a cell model of HD. However, as valuable as this model is, the differentiation to medium spiny neurons is very long, cumbersome and expensive, making study of the cells and screening for therapeutics very difficult. We therefore now propose to generate immortalized striatal precursors from the HD iPS cells. In Specific Aim 1, we will use HD and control iPS cells differentiated to striatal precursors for immortalization with viral vectors, and
optimize protocols for differentiation to neurons with a mature striatal medium spiny neuron phenotype. In Specific Aim 2, we will assess the cells for CAG- repeat-expansion-dependent toxicity and rescue, and format the model as a screenable assay. These studies taken together will permit the development of a novel cell model of HD which will have features similar to the iPS cell model, but be more reproducible and tractable. These cells should be very valuable for studying HD pathogenesis and for screening for novel neuroprotective therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LRRK2 and inflammasome pathway in Parkinson's disease
-
批准号:10292714
-
项目类别:
-
资助金额:$67.31万
-
财政年份:2021
-
负责人:Christopher A Ross
-
依托单位:
LRRK2 and inflammasome pathway in Parkinson's disease
-
批准号:10432114
-
项目类别:
-
资助金额:$65.86万
-
财政年份:2021
-
负责人:Christopher A Ross
-
依托单位:
LRRK2 and inflammasome pathway in Parkinson's disease
-
批准号:10640900
-
项目类别:
-
资助金额:$64.29万
-
财政年份:2021
-
负责人:Christopher A Ross
-
依托单位:
Immortalized Striatal Precursor Neurons as a Screenable Model of HD
-
批准号:10550333
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2018
-
负责人:Christopher A Ross
-
依托单位:
Validation of Novel Pathogenic Htt Post-Translational Modifications (PTMs)
-
批准号:9008084
-
项目类别:
-
资助金额:$62.65万
-
财政年份:2014
-
负责人:Christopher A Ross
-
依托单位:
Validation of Novel Pathogenic Htt Post-Translational Modifications (PTMs)
-
批准号:9222822
-
项目类别:
-
资助金额:$61.57万
-
财政年份:2014
-
负责人:Christopher A Ross
-
依托单位:
Validation of Novel Pathogenic Post-Translational Modifications of Huntingtin, and of Modifying Enzymes as Therapeutic Targets for Huntington's Disease
-
批准号:10599877
-
项目类别:
-
资助金额:$57.38万
-
财政年份:2014
-
负责人:Christopher A Ross
-
依托单位:
Validation of Novel Pathogenic Htt Post-Translational Modifications (PTMs)
-
批准号:8826197
-
项目类别:
-
资助金额:$62.65万
-
财政年份:2014
-
负责人:Christopher A Ross
-
依托单位:
Validation of Novel Pathogenic Htt Post-Translational Modifications (PTMs)
-
批准号:8659881
-
项目类别:
-
资助金额:$62.65万
-
财政年份:2014
-
负责人:Christopher A Ross
-
依托单位:
Immortalized Human Strital Precursors as a Cell Model of HD
-
批准号:8616821
-
项目类别:
-
资助金额:$20.05万
-
财政年份:2013
-
负责人:Christopher A Ross
-
依托单位:
Parkinson's Disease Mouse Model with Mutant LRRK2
-
批准号:8069017
-
项目类别:
-
资助金额:$24.6万
-
财政年份:2010
-
负责人:Christopher A Ross
-
依托单位:
Parkinson's Disease Mouse Model with Mutant LRRK2
-
批准号:8144791
-
项目类别:
-
资助金额:$20.09万
-
财政年份:2010
-
负责人:Christopher A Ross
-
依托单位:
HUNTINGTIN MICROAGGREGATES AND CELL TOXICITY: LIVE CELL IMAGING
-
批准号:7957618
-
项目类别:
-
资助金额:$1.56万
-
财政年份:2009
-
负责人:Christopher A Ross
-
依托单位:
PREQUEL Study In PRE-manifest HD of CoQ10/UbiquinonE Leading to Preventive Trials
-
批准号:7942954
-
项目类别:
-
资助金额:$122.2万
-
财政年份:2008
-
负责人:Christopher A Ross
-
依托单位:
PREQUEL Study In PRE-manifest HD of CoQ10/UbiquinonE Leading to Preventive Trials
-
批准号:7474434
-
项目类别:
-
资助金额:$118.28万
-
财政年份:2008
-
负责人:Christopher A Ross
-
依托单位:
HUNTINGTIN MICROAGGREGATES AND CELL TOXICITY: LIVE CELL IMAGING
-
批准号:7722441
-
项目类别:
-
资助金额:$0.98万
-
财政年份:2008
-
负责人:Christopher A Ross
-
依托单位:
PREQUEL Study In PRE-manifest HD of CoQ10/UbiquinonE Leading to Preventive Trials
-
批准号:7647899
-
项目类别:
-
资助金额:$135.13万
-
财政年份:2008
-
负责人:Christopher A Ross
-
依托单位:
LRRK2 and Parkinson's Disease Cell Biology
-
批准号:7462285
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2007
-
负责人:Christopher A Ross
-
依托单位:
LRRK2 and Parkinson's Disease Cell Biology
-
批准号:7643789
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2007
-
负责人:Christopher A Ross
-
依托单位:
LRRK2 and Parkinson's Disease Cell Biology
-
批准号:7891269
-
项目类别:
-
资助金额:$35.52万
-
财政年份:2007
-
负责人:Christopher A Ross
-
依托单位:
海外基金